ONVO stock is getting a lot of attention on Thursday as Organovo Holdings Inc (NASDAQ:ONVO) announcesd a collaboration with MCRI and Leiden University Medical Center to develop stem cell-based bioprinted tissue treatments for kidney disease.
The San Diego, California based biotechnology company Organovo has been a pioneer in developing bioprinted 3D tissues that could be used to treat a wide range of diseases.
ONVO Stock Jumps 90%Currently, the company is engaged in a range of IND track programs in order to develop its product NovoTissues and in a new development, it has established ...
Read The Full Article On MicroSmallCap.com
Get early insight on hidden secret gems on MicroSmallCap. Follow Crypto, Mining, Cannabis and Energy stocks and get free research reports here.
All content provided by MicroSmallCap is subject to our Terms Of Use and Disclaimer.